SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-12
👔
Cytek Biosciences, Inc.
@CTKB_InsiderForm 4 Filing: Feuchtwang Ilan Acquires (Grant) shares of $CTKB
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Cytek Biosciences, Inc.
Ticker: $CTKB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-10
Shares: 368,534
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Feuchtwang Ilan, holds the title of Chief Legal Officer, Secretary at Cytek Biosciences, Inc..
On 2026-08-10, the insider transacted 368,534 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Feuchtwang Ilan (Chief Legal Officer, Secretary) was granted $0 of $CTKB
Post-Transaction Position: 241,416 shares
SEC Accession No: 0002141966-26-000002 (CIK: 2141966)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.